Skip to main content
Main navigation
Home
Browse
Upcoming Live
On Demand
Podcasts
All
About Us
Login
Register
Browse
Search by Speaker, Therapeutic Area, Series...
Therapeutic Area
- Any -
Allergies
Cardiovascular
Diabetes
Neurology
Women's Health
Format
- Any -
Upcoming Live Programs
On Demand
Podcast
Accreditation
- Any -
NON-ACCREDITED
CCCEP
CFPC
FMOQ
RCPSC
Series
- Any -
Breaking News
CAN-R³: Canadian Initiative to Reduce Residual Risk
Diabetes Update 2022 - Podcast Series
HF21
Top 3 HF Conundrums
Podcast
11:26
June 20, 2022
Diabetes Update 2022 Podcast Series
Let’s Be Friends: A Collaborative Conversation between Endocrinology and Cardiology
On Demand
59:51
May 10, 2022
A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in C
A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in CKD
Upcoming Live Programs
3 days
April 24, 2025
DUO25 | April 24-26, 2025
Register now for DUO25, a hybrid congress that unites obesity & diabetes HCP's in Canada.
Upcoming Live Programs
February 27, 2025
Arrhythmia Update 2025
Save the Date!
Upcoming Live Programs
February 21, 2025
Clinical Cardiology & Care Update 2025 (IN PERSON)
This new one-day conference will be held at U of T: Schwartz Reisman Innovation Campus
On Demand
5 hours
October 25, 2024
Pearls for Primary Care 2024
Pearls for Primary Care 2024
On Demand
August 25, 2023
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Dosing FAQs
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Dosing FAQs
On Demand
03:02
July 18, 2023
AIM-LO: Statins + Ezetimibe
AIM-LO: Statins + Ezetimibe
On Demand
03:37
July 18, 2023
AIM-LO: LDL-C: Lower for Longer is Better
AIM-LO: LDL-C: Lower for Longer is Better
On Demand
06:18
July 18, 2023
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data
On Demand
03:03
July 18, 2023
AIM-LO: Icosapent ethyl (IPE)
AIM-LO: Icosapent ethyl (IPE)
On Demand
06:14
July 18, 2023
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action
AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action
On Demand
03:14
July 18, 2023
AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients
AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients
On Demand
04:48
July 18, 2023
AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for
Engaging With Your Patients about Selection of Injectable Therapies for LDL-C Reduction
On Demand
03:14
July 18, 2023
AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus Secondary Prevention
AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus on Secondary Prevention
Podcast
April 15, 2023
Diabetes Update 2023 Podcast Series
Optimal Treatment of Lipids: Who and When?
Pagination
Page
1
Page
2
Page
3
Page
4
Next page
››
Last page
Last »
